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Although recruited macrophages play a central role in liver fibrogenesis,
evidence has shown divergent roles of recruited macrophages in fibrosis progression
and reversal. This might be mediated by functionally opposing subpopulations of
Ly6C+(Gr1+) macrophages. Folate receptor Beta (FR-β) has been found to be
expressed on macrophages in arthritis and pneumonia. The expression of FR-β in liver
fibrosis has not been reported, and the study on whether FR-β can be used as a marker
of monocyte macrophages subpopulations has not been studied.
Here we report that folate receptor-β (FR-β) expression identifies two
functionally distinct subsets of hepatic Ly6C+ macrophages during liver fibrosis:
FR-β+Ly6C+ and FR-β-Ly6C+ cells. The FR-β+Ly6C+ subset plays a critical role in
promoting hepatic fibrosis and initiating liver progenitor cell-mediated liver
regeneration, whereas FR-β-Ly6C+ macrophages are associated with fibrosis
resolution. They have a distinct pattern of cytokine expression.
Furthermore, Hypoxia inducible factor -1 alpha (HIF-1α) activation in response
to liver damage is critical for the regulation of FR-β expression and differentiation of
two subsets of hepatic Ly6C+ macrophages. HIF-1α can promote the expression of
FR-β, increase the expression of TNF-α and TGF-β, and promote the development of
fibrosis.
In addition, The expression of FR-β was closely correlated with the stage of liver
fibrosis. With the characteristic of ASGPR, we explored SPECT imaging based on
FR-β and ASGPR to differentiate liver fibrosis stage and quantify liver inflammation
and fibrogenesis, which would be a novel target for hepatic fibrosis diagnosis and
therapy.
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因有慢性的肝炎病毒 B 或 C、自免疫以及肥胖疾病、酒精性脂肪肝炎(ASH)、非
酒精性脂肪肝炎(NASH)等[1,2]。现在人们越来越重视其中非酒精性脂肪肝的研
究，普遍认为其不再是良性病变，而是可以发展为肝纤维化、肝硬化的前期病症，
甚至会导致一系列严重并发症。临床上 NASH 确诊时，已经有 5-15% 病人合并
为肝纤维化，此类患者在 10 年后有 30% 发展为肝硬化. 整个 NASH 最终肝硬化
的发生率为 15-50%，3%合并急性肝功能衰竭，极个别可发生肝细胞癌.NASH 5






















































































































































































损增加，因此表达 ASGPR减少，对于特异性靶向 ASGPR 的 125I-NGA 探针的摄
取逐渐减少。4.根据纤维化不同阶段小鼠肝脏对于 99mTc-HYNIC-D1-FA2探针和
125I-NGA 探针摄取的变化，可以有望通过使用 99mTc-HYNIC-D1-FA2 探针和





















第二章 CCl4诱导 C57Bl/6J 小鼠慢性肝损伤模型和高脂高胆固醇饮食诱导 ApoE 基因敲除小
鼠脂肪性肝炎肝纤维化模型建立与评估
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